As several coronavirus vaccines inch closer toward FDA approval, the nation’s leading infectious disease expert has called on the public to double-down on public health measures.
Oxford University and AstraZeneca's coronavirus vaccine candidate was safe, boosted an immune response, and was better tolerated among older adults, according to phase 2 clinical trial data.
Scale back holiday gatherings this year, urged several leading medical and health organizations in an open letter to the American people as coronavirus cases surge across the country.
In a telebriefing held Thursday, the Centers for Disease Control and Prevention (CDC) warned against traveling to visit relatives and friends this Thanksgiving and holiday season and urged those with possible coronavirus symptoms or other illnesses to stay home.
Advocates for the elderly say a tandem wave of death separate from the virus has quietly claimed tens of thousands more, often because overburdened workers haven’t been able to give them the care they need.
The novel coronavirus has claimed more than 250,000 American lives as of Wednesday evening, according to the latest estimates from Johns Hopkins University.
The decision by New York City officials to temporarily close schools to in-person instruction due to an uptick in coronavirus cases makes little sense because "children really are not affected by this virus," Dr. Bob Lahita told "Your World" Wednesday.
Johnson & Johnson’s lead scientist said the company expects to have all data needed to file for authorization for its single-shot coronavirus vaccine candidate by February, according to a report.
Pfizer and BioNTech said its vaccine was found to be safe and 95% effective in phase 3 clinical trial, clearing the way for the companies to file for emergency use authorization with the FDA.